Current status of interleukin-10 and regulatory T-cells in cancer

Interleukin-10 and the Interleukin-10 Receptor

Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · see citing works

Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells

Park, J., Adoro, S., Guinter, T. I., Erman, B., Alag, A., Catálfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835 · see citing works

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608 · see citing works

The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells

Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145 · see citing works

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742 · see citing works

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265 · see citing works

A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene

Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039 · see citing works

IL-10 inhibits cytokine production by activated macrophages

Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888 · see citing works

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733 · see citing works

Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells

Pasare, C., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1078231 · Cited by 2,327 · see citing works

Inflammation and Colon Cancer

Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974 · see citing works

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898 · see citing works

Interleukin-10

Moore, K. W., O’Garra, A., Malefyt, R. D. W., Vieira, P., & Mosmann, T. R. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001121 · Cited by 1,883 · see citing works

Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis

Rioux, J. D., Xavier, R. J., Taylor, K. D., Silverberg, M. S., Goyette, P., Huett, A., Green, T., Kuballa, P., Barmada, M. M., Datta, L. W., et al. (2007) · Nature Genetics · doi:10.1038/ng2032 · Cited by 1,769 · see citing works

B cells regulate autoimmunity by provision of IL-10

Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647 · see citing works

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

Janssen, E. M., Lemmens, E. E., Wolfe, T., Christen, U., von Herrath, M. G., & Schoenberger, S. P. (2003) · Nature · doi:10.1038/nature01441 · Cited by 1,635 · see citing works

An Essential Role for Interleukin 10 in the Function of Regulatory T Cells That Inhibit Intestinal Inflammation

Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., & Powrie, F. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.995 · Cited by 1,617 · see citing works

T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ

Yang, X. O., Pappu, B. P., Nurieva, R., Akimzhanov, A., Kang, H. S., Chung, Y., Ma, L., Shah, B., Panopoulos, A. D., Schluns, K. S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.016 · Cited by 1,605 · see citing works

Regulatory T Cell-Derived Interleukin-10 Limits Inflammation at Environmental Interfaces

Rubtsov, Y. P., Rasmussen, J. P., Chi, E. Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P., Siewe, L., Roers, A., Henderson, W. R., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.017 · Cited by 1,586 · see citing works

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

Shedlock, D. J., & Shen, H. (2003) · Science · doi:10.1126/science.1082305 · Cited by 1,450 · see citing works

Adenoma–linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth

Grivennikov, S. I., Wang, K., Mucida, D., Stewart, C. A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G.-Y., Österreicher, C. H., Hung, K. E., et al. (2012) · Nature · doi:10.1038/nature11465 · Cited by 1,327 · see citing works

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity

Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314 · see citing works

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

Sun, J. C., & Bevan, M. J. (2003) · Science · doi:10.1126/science.1083317 · Cited by 1,213 · see citing works

Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen

Akbari, O., DeKruyff, R. H., & Umetsu, D. T. (2001) · Nature Immunology · doi:10.1038/90667 · Cited by 1,196 · see citing works

Regulatory T cells in the control of immune pathology

Maloy, K. J., & Powrie, F. M. (2001) · Nature Immunology · doi:10.1038/ni0901-816 · Cited by 1,177 · see citing works

Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans

Roncarolo, M. G., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K., & Levings, M. K. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00420.x · Cited by 1,174 · see citing works

Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer

Tosolini, M., Kirilovsky, A., Mlecnik, B., Fredriksen, T., Mauger, S., Bindea, G., Berger, A., Bruneval, P., Fridman, W.-H., Pagès, F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2907 · Cited by 1,146 · see citing works

IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3− effector T cells

Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R. A., Mitsdoerffer, M., Strom, T. B., Elyaman, W., Ho, I.-C., et al. (2008) · Nature Immunology · doi:10.1038/ni.1677 · Cited by 1,122 · see citing works

Th17 and regulatory T cells in mediating and restraining inflammation

Littman, D. R., & Rudensky, A. Y. (2010) · Cell · doi:10.1016/j.cell.2010.02.021 · Cited by 1,039 · see citing works

Tumor-Infiltrating FOXP3 + T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

Salama, P. R., Phillips, M. R., Grieu, F., Morris, M. J., Zeps, N., Joseph, D. J., Platell, C. F. E., & Iacopetta, B. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.7229 · Cited by 992 · see citing works

TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells

Marie, J. C., Letterio, J. J., Gavin, M. A., & Rudensky, A. Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042276 · Cited by 986 · see citing works

Interleukin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated Inflammation

Chaudhry, A., Samstein, R. M., Treuting, P., Liang, Y., Pils, M. C., Heinrich, J.-M., Jack, R. S., Wunderlich, F. T., Brüning, J. C., Müller, W., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.018 · Cited by 980 · see citing works

Interleukin-10 Therapy—Review of a New Approach

Asadullah, K., Sterry, W., & Volk, H. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.4 · Cited by 941 · see citing works

Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production

Prete, G. D., Carli, M., Almerigogna, F., Giudizi, M. G., Biagiotti, R., & Romagnani, S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.2.353 · Cited by 927 · see citing works

Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells

Groux, H., Bigler, M., de Vries, J. D., & Roncarolo, M. (1996) · Journal of Experimental Medicine · doi:10.1084/jem.184.1.19 · Cited by 876 · see citing works

Prevention of Arthritis by Interleukin 10–producing B Cells

Mauri, C., Gray, D., Mushtaq, N., & Londei, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021293 · Cited by 858 · see citing works

Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis

Murai, M., Turovskaya, O., Kim, G., Madan, R., Karp, C. L., Cheroutre, H., & Kronenberg, M. (2009) · Nature Immunology · doi:10.1038/ni.1791 · Cited by 851 · see citing works

SOCS3 negatively regulates IL-6 signaling in vivo

Croker, B. A., Krebs, D. L., Zhang, J.-G., Wormald, S., Willson, T. A., Stanley, E. G., Robb, L., Greenhalgh, C. J., Förster, I., Clausen, B. E., et al. (2003) · Nature Immunology · doi:10.1038/ni931 · Cited by 840 · see citing works

Tumor-specific Th17-polarized cells eradicate large established melanoma

Muranski, P. J., Boni, A., Antony, P. A., Cassard, L., Irvine, K. R., Kaiser, A., Paulos, C. M., Palmer, D. C., Touloukian, C. E., Ptak, K., et al. (2008) · Blood · doi:10.1182/blood-2007-11-120998 · Cited by 838 · see citing works

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

Grakoui, A., Shoukry, N. H., Woollard, D. J., Han, J., Hanson, H. L., Ghrayeb, J., Murthy, K. K., Rice, C. M., & Walker, C. M. (2003) · Science · doi:10.1126/science.1088774 · Cited by 824 · see citing works

Type 1 T regulatory cells

Roncarolo, M. G., Bacchetta, R., Bordignon, C., Narula, S. K., & Levings, M. K. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820105.x · Cited by 814 · see citing works

A dominant function for interleukin 27 in generating interleukin 10–producing anti-inflammatory T cells

Awasthi, A., Carrier, Y., Peron, J. P. S., Bettelli, E., Kamanaka, M., Flavell, R. A., Kuchroo, V. K., Oukka, M., & Weiner, H. L. (2007) · Nature Immunology · doi:10.1038/ni1541 · Cited by 804 · see citing works

T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity

Martín‐Orozco, N., Muranski, P. J., Chung, Y., Yang, X. O., Yamazaki, T., Lu, S., Hwu, P., Restifo, N. P., Overwijk, W. W., & Dong, C. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.014 · Cited by 797 · see citing works

Characterization of Dendritic Cells that Induce Tolerance and T Regulatory 1 Cell Differentiation In Vivo

Wakkach, A., Fournier, N., Brun, V., Breittmayer, J., Cottrez, F., & Groux, H. (2003) · Immunity · doi:10.1016/s1074-7613(03)00113-4 · Cited by 788 · see citing works

Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10

Stumhofer, J. S., Silver, J. S., Laurence, A. D. J., Porrett, P. M., Harris, T. H., Turka, L. A., Ernst, M., Saris, C. J. M., O’Shea, J. J., & Hunter, C. A. (2007) · Nature Immunology · doi:10.1038/ni1537 · Cited by 777 · see citing works

Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI.

Vieira, P., Malefyt, R. D. W., Dang, M. N., Johnson, K. E., KASTELEIN, R. A., Fiorentino, D. F., Devriès, J., Roncarolo, M., Mosmann, T. R., & Moore, K. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1172 · Cited by 740 · see citing works

CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent Mechanisms

Maloy, K. J., Salaün, L., Cahill, R., Dougan, G., Saunders, N. J. S. G., & Powrie, F. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021345 · Cited by 740 · see citing works

Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells

Chen, Z. J., Laurence, A. D. J., Kanno, Y., Pacher-Zavisin, M. C., Zhu, B., Tato, C. M., Yoshimura, A., Hennighausen, L. G., & O’Shea, J. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600666103 · Cited by 648 · see citing works

Control of TH17 cells occurs in the small intestine

Esplugues, E., Huber, S., Gagliani, N., Hauser, A. E., Town, T., Wan, Y. Y., O’Connor, W., Rongvaux, A., van Rooijen, N., Haberman, A. M., et al. (2011) · Nature · doi:10.1038/nature10228 · Cited by 643 · see citing works

Pathogen-specific T Regulatory 1 Cells Induced in the Respiratory Tract by a Bacterial Molecule that Stimulates Interleukin 10 Production by Dendritic Cells

McGuirk, P., McCann, C., & Mills, K. H. G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011288 · Cited by 617 · see citing works

TH1 cells control themselves by producing interleukin-10

O’Garra, A., & Vieira, P. (2007) · Nature reviews. Immunology · doi:10.1038/nri2097 · Cited by 614 · see citing works

Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-10

Lang, R., Patel, D. H., Morris, J. J., Rutschman, R. L., & Murray, P. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2253 · Cited by 613 · see citing works

Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation

Malefyt, R. D. W., Yssel, H., & de Vries, J. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.11.4754 · Cited by 610 · see citing works

Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3− precursor cells in the absence of interleukin 10

Maynard, C. L., Harrington, L. E., Janowski, K. M., Oliver, J. R., Zindl, C. L., Rudensky, A. Y., & Weaver, C. T. (2007) · Nature Immunology · doi:10.1038/ni1504 · Cited by 599 · see citing works

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

Badoual, C., Hans, S., Rodriguez, J., Peyrard, S., Klein, C., Agueznay, N. E. H., Mosseri, V., Laccourreye, O., Bruneval, P., Fridman, W. H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1886 · Cited by 595 · see citing works

IFN-α and IL-10 Induce the Differentiation of Human Type 1 T Regulatory Cells

Levings, M. K., Sangregorio, R., Galbiati, F., Squadrone, S., Malefyt, R. D. W., & Roncarolo, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5530 · Cited by 595 · see citing works

Conventional T-bet+Foxp3− Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection

Jankovic, D. L., Kullberg, M. C., Feng, C. G., Goldszmid, R. S., Collazo, C. M., Wilson, M. D., Wynn, T. A., Kamanaka, M., Flavell, R. A., & Sher, A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062175 · Cited by 590 · see citing works

Th17 Cells Express Interleukin-10 Receptor and Are Controlled by Foxp3− and Foxp3+ Regulatory CD4+ T Cells in an Interleukin-10-Dependent Manner

Huber, S., Gagliani, N., Esplugues, E., O'Connor, W., Huber, F. J., Chaudhry, A., Kamanaka, M., Kobayashi, Y., Booth, C. J., Rudensky, A. Y., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.01.020 · Cited by 581 · see citing works

CD4+CD25−Foxp3− Th1 cells are the source of IL-10–mediated immune suppression in chronic cutaneous leishmaniasis

Anderson, C. F., Oukka, M., Kuchroo, V. K., & Sacks, D. L. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061886 · Cited by 571 · see citing works

The Role of Interleukin (IL)-10 in the Persistence of <i>Leishmania major</i> in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile Cure

Belkaid, Y., Hoffmann, K. F., Mendez, S., Kamhawi, S., Udey, M. C., Wynn, T. A., & Sacks, D. L. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1497 · Cited by 557 · see citing works

How Tolerogenic Dendritic Cells Induce Regulatory T Cells

Maldonado, R., & von Andrian, U. H. (2010) · Advances in immunology · doi:10.1016/b978-0-12-380995-7.00004-5 · Cited by 543 · see citing works

Two Functional Subsets of FOXP3+ Regulatory T Cells in Human Thymus and Periphery

Ito, T., Hanabuchi, S., Wang, Y.-H., Park, W. R., Arima, K., Bover, L. C., Qin, F. X.-F., Gilliet, M. F., & Liu, Y. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.018 · Cited by 541 · see citing works

IL-10–producing and naturally occurring CD4+ Tregs: limiting collateral damage

O’Garra, A., Vieira, P. L., Vieira, P., & Goldfeld, A. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci23215 · Cited by 530 · see citing works

Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27–stimulated T cells

Fitzgerald, D. C., Zhang, G.-X., El-Behi, M., Fonseca-Kelly, Z., Li, H., Yu, S., Saris, C. J. M., Gran, B., Ciric, B., & Rostami, A. (2007) · Nature Immunology · doi:10.1038/ni1540 · Cited by 529 · see citing works

Ly‐1 B (B‐1) cells are the main source of B cell‐derived interleukin 10

O’Garra, A., Chang, R., Go, N. F., Hastings, R., Haughton, G., & Howard, M. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220314 · Cited by 525 · see citing works

Interleukin-10–Treated Human Dendritic Cells Induce a Melanoma-Antigen–Specific Anergy in CD8+ T Cells Resulting in a Failure to Lyse Tumor Cells

Steinbrink, K., Jonuleit, H., Müller, G., Schuler, G., Knop, J., & Enk, A. (1999) · Blood · doi:10.1182/blood.v93.5.1634 · Cited by 509 · see citing works

Tumour‐infiltrating T‐cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review

Nosho, K., Baba, Y., Tanaka, N., Shima, K., Hayashi, M., Meyerhardt, J. A., Giovannucci, E., Dranoff, G., Fuchs, C. S., & Ogino, S. (2010) · The Journal of Pathology · doi:10.1002/path.2774 · Cited by 502 · see citing works

Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells.

Go, N. F., Castle, B. E., Barrett, R., KASTELEIN, R. A., Dang, W., Mosmann, T. R., Moore, K. W., & Howard, M. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.6.1625 · Cited by 475 · see citing works

Cutting Edge: IL-27 Induces the Transcription Factor c-Maf, Cytokine IL-21, and the Costimulatory Receptor ICOS that Coordinately Act Together to Promote Differentiation of IL-10-Producing Tr1 Cells

Pot, C., Jin, H., Awasthi, A., Liu, S. M., Lai, C.-Y., Madan, R., Sharpe, A. H., Karp, C. L., Miaw, S., Ho, I., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901233 · Cited by 466 · see citing works

Specific Inhibition of Cyclooxygenase 2 Restores Antitumor Reactivity by Altering the Balance of IL-10 and IL-12 Synthesis

Stolina, M., Sharma, S. P., Lin, Y., Dohadwala, M., Gardner, B. K., Luo, J., Zhu, L. X., Kronenberg, M., Miller, P. W., Portanova, J. P., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.361 · Cited by 465 · see citing works

A Toll-Like Receptor 2 Ligand Stimulates Th2 Responses In Vivo, via Induction of Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase and c-Fos in Dendritic Cells

Dillon, S. M., Agrawal, A., Dyke, T. E. V., Landreth, G. E., McCauley, L. K., Koh, A. J., Maliszewski, C. R., Akira, S., & Pulendran, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4733 · Cited by 460 · see citing works

CD4+ and CD8+ anergic T cells induced by interleukin-10–treated human dendritic cells display antigen-specific suppressor activity

Steinbrink, K., Graulich, E., Kubsch, S., Knop, J., & Enk, A. (2002) · Blood · doi:10.1182/blood.v99.7.2468 · Cited by 448 · see citing works

Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response

MURRAY, P. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.01.010 · Cited by 436 · see citing works

Recombinant Human IL-10 Prevents the Onset of Diabetes in the Nonobese Diabetic Mouse

Pennline, K. J., Roque-Gaffney, E., & Monahan, M. (1994) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1994.1068 · Cited by 428 · see citing works

The Role of IL-10 and TGF-β in the Differentiation and Effector Function of T Regulatory Cells

Levings, M. K., Bacchetta, R., Schulz, U., & Roncarolo, M. G. (2002) · International Archives of Allergy and Immunology · doi:10.1159/000067596 · Cited by 423 · see citing works

Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment

Gajewski, T. F., Woo, S., Zha, Y., Spaapen, R. M., Zheng, Y., Corrales, L. P., & Spranger, S. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.02.009 · Cited by 420 · see citing works

IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance

Mumm, J. B., Emmerich, J., Zhang, X., Chan, I., Wu, L., Mauze, S., Blaisdell, S., Basham, B., Dai, J., Grein, J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.003 · Cited by 418 · see citing works

Diversity in the contribution of interleukin‐10 to T‐cell‐mediated immune regulation

Maynard, C. L., & Weaver, C. T. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00711.x · Cited by 404 · see citing works

Interleukin-10 and the immune response against cancer: a counterpoint

D, S. M. M., Marincola, F. M., & Young, H. A. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0705358 · Cited by 400 · see citing works

Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis

Scott-Browne, J. P., Shafiani, S., Tucker-Heard, G., Ishida-Tsubota, K., Fontenot, J. D., Rudensky, A. Y., Bevan, M. J., & Urdahl, K. B. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062105 · Cited by 399 · see citing works

The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription

Murray, P. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500419102 · Cited by 394 · see citing works

Expression of Interleukin-10 in Intestinal Lymphocytes Detected by an Interleukin-10 Reporter Knockin tiger Mouse

Kamanaka, M., Kim, S. T., Wan, Y. Y., Sutterwala, F. S., Lara-Tejero, M., Galán, J. E., Harhaj, E., & Flavell, R. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.09.013 · Cited by 392 · see citing works

IL-10: a novel cytotoxic T cell differentiation factor

Chen, W. F., & Zlotnik, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.2.528 · Cited by 385 · see citing works

Mechanisms of interleukin‐10‐mediated immune suppression

Akdiş, C. A., & Blaser, K. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01235.x · Cited by 381 · see citing works

Transcriptional reprogramming of mature CD4+ helper T cells generates distinct MHC class II–restricted cytotoxic T lymphocytes

Mucida, D., Husain, M. M., Muroi, S., van Wijk, F., Shinnakasu, R., Naoe, Y., Reis, B. S., Huang, Y., Lambolez, F., Docherty, M., et al. (2013) · Nature Immunology · doi:10.1038/ni.2523 · Cited by 376 · see citing works

Interleukin-10 production by effector T cells: Th1 cells show self control

Trinchieri, G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070104 · Cited by 373 · see citing works

Inhibitory and Stimulatory Effects of IL-10 on Human CD8+ T Cells

Groux, H., Bigler, M., de Vries, J. E., & Roncarolo, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3188 · Cited by 373 · see citing works

IL-10, a novel growth cofactor for mature and immature T cells.

MacNeil, I. A., Suda, T., Moore, K. W., Mosmann, T. R., & Zlotnik, A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4167 · Cited by 360 · see citing works

Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10

O’Garra, A., Stapleton, G., Dhar, V., Pearce, M. K., Schumacher, J., Rugo, H. S., Barbls, D., Stall, A. M., Cupp, J., Moore, K. W., et al. (1990) · International Immunology · doi:10.1093/intimm/2.9.821 · Cited by 344 · see citing works

Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody

Vicari, A. P., Chiodoni, C., Vaure, C., Aït-Yahia, S., Dercamp, C., Matsos, F., Reynard, O., Taverne, C., Merle, P., Colombo, M. P., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020732 · Cited by 343 · see citing works

High frequency of tumor‐infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair‐proficient colorectal cancer patients

Frey, D. M., Droeser, R. A., Viehl, C. T., Zlobec, I., Lugli, A., Zingg, U., Oertli, D., Kettelhack, C., Terracciano, L., & Tornillo, L. (2009) · International Journal of Cancer · doi:10.1002/ijc.24989 · Cited by 335 · see citing works

IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response

Kim, J., Modlin, R. L., Moy, R. L., Dubinett, S. M., McHugh, T. M., Nickoloff, B. J., & Uyemura, K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.2240 · Cited by 323 · see citing works

Adenomatous Polyps Are Driven by Microbe-Instigated Focal Inflammation and Are Controlled by IL-10–Producing T Cells

Dennis, K. L., Wang, Y., Blatner, N. R., Wang, S., Saadalla, A. M., Trudeau, E., Roers, A., Weaver, C. T., Lee, J. J., Gilbert, J. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1511 · Cited by 316 · see citing works

Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation.

Plaen, E. D., Lurquin, C., Pel, A. V., Mariamé, B., Szikora, J., Wölfel, T., Sibille, C., Chomez, P., & Boon, T. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2274 · Cited by 309 · see citing works

Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis

Shafiani, S., Tucker-Heard, G., Kariyone, A., Takatsu, K., & Urdahl, K. B. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091885 · Cited by 309 · see citing works

Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A

Santo, C. D., Arscott, R., Booth, S., Karydis, I., Jones, M., Asher, R. G., Salio, M., Middleton, M. R., & Cerundolo, V. (2010) · Nature Immunology · doi:10.1038/ni.1942 · Cited by 304 · see citing works

CD4+ CD25+ Regulatory T Lymphocytes Inhibit Microbially Induced Colon Cancer in Rag2-Deficient Mice

Erdman, S. E., Poutahidis, T., Tomczak, M. F., Rogers, A. B., Cormier, K. S., Plank, B., Horwitz, B. H., & Fox, J. G. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63863-1 · Cited by 303 · see citing works

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice.

den Eynde, B. J. V., Lethé, B., Pel, A. V., Plaen, E. D., & Boon, T. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.6.1373 · Cited by 298 · see citing works

Human interleukin-10 can directly inhibit T-cell growth

Taga, K., Mostowski, H., & Tosato, G. (1993) · Blood · doi:10.1182/blood.v81.11.2964.2964 · Cited by 288 · see citing works

Macrophages and Myeloid Dendritic Cells, but Not Plasmacytoid Dendritic Cells, Produce IL-10 in Response to MyD88- and TRIF-Dependent TLR Signals, and TLR-Independent Signals

Boonstra, A., Rajsbaum, R., Holman, M. J., Marques, R., Asselin‐Paturel, C., Pereira, J. P., Bates, E. E. M., Akira, S., Vieira, P., Liu, Y., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7551 · Cited by 288 · see citing works

CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion

Kavanagh, B., O'Brien, S., Lee, D., Hou, Y., Weinberg, V., Rini, B., Allison, J. P., Small, E. J., & Fong, L. (2008) · Blood · doi:10.1182/blood-2007-11-125435 · Cited by 256 · see citing works

In the Absence of IL-12, CD4+ T Cell Responses to Intracellular Pathogens Fail to Default to a Th2 Pattern and Are Host Protective in an IL-10−/− Setting

Jankovic, D. L., Kullberg, M. C., Hieny, S. E., Caspar, P., Collazo, C. M., & Sher, A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00278-9 · Cited by 252 · see citing works

Mast cells are an essential hematopoietic component for polyp development

Gounaris, E. G., Erdman, S. E., Restaino, C. R., Gurish, M. F., Friend, D. S., Gounari, F., Lee, D. M., Zhang, G., Glickman, J. N., Shin, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704620104 · Cited by 251 · see citing works

A Transgenic Model to Analyze the Immunoregulatory Role of IL-10 Secreted by Antigen-Presenting Cells

Groux, H., Cottrez, F., Rouleau, M., Mauze, S., Antonenko, S. V., Hurst, S. D., McNeil, T., Bigler, M., Roncarolo, M., & Coffman, R. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1723 · Cited by 246 · see citing works

The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle

D, S. M. M., Marincola, F. M., Rossi, C. R., Nitti, D., & Lise, M. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.11.001 · Cited by 246 · see citing works

Th17 Cells Upregulate Polymeric Ig Receptor and Intestinal IgA and Contribute to Intestinal Homeostasis

Cao, A., Yao, S., Gong, B., Elson, C. O., & Cong, Y. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200955 · Cited by 244 · see citing works

Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism.

Zheng, L., Ojcius, D. M., Garaud, F., Roth, C., Maxwell, E., Li, Z., Rong, H., Chen, J., Wang, X., Catino, J. J., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.579 · Cited by 230 · see citing works

Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy

Peggs, K. S., Quezada, S. A., & Allison, J. P. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00649.x · Cited by 228 · see citing works

Microbial Recognition Via Toll-Like Receptor-Dependent and -Independent Pathways Determines the Cytokine Response of Murine Dendritic Cell Subsets to CD40 Triggering

Edwards, A. D., Manickasingham, S. P., Spörri, R., Diebold, S. S., Schulz, O., Sher, A., Kaisho, T., Akira, S., & Sousa, C. R. E. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3652 · Cited by 226 · see citing works

Type 17 CD8+ T cells display enhanced antitumor immunity

Hinrichs, C. S., Kaiser, A., Paulos, C. M., Cassard, L., Sanchez-Perez, L. A., Heemskerk, B., Wrzesinski, C., Borman, Z. A., Muranski, P. J., & Restifo, N. P. (2009) · Blood · doi:10.1182/blood-2009-02-203935 · Cited by 226 · see citing works

The significant role of mast cells in cancer

Khazaie, K., Blatner, N. R., Khan, M. W., Gounari, F., Gounaris, E. G., Dennis, K. L., Bonertz, A., Tsai, F., Strouch, M. J., Cheon, E. C., et al. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9286-z · Cited by 223 · see citing works

Anti-CTLA-4 therapy results in higher CD4 ⁺ ICOS ^hi T cell frequency and IFN-γ levels in both nonmalignant and malignant prostate tissues

Chen, H., Liakou, C. I., Kamat, A., Pettaway, C., Ward, J. F., Tang, D. N., Sun, J., Jungbluth, A. A., Troncoso, P., Logothetis, C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813175106 · Cited by 218 · see citing works

Interleukin 10 Secretion and Impaired Effector Function of Major Histocompatibility Complex Class II–restricted T Cells Anergized In Vivo

Buer, J., Lanoue, A., Franzke, A., Cordier, C., von Boehmer, H., & Sarukhan, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.177 · Cited by 214 · see citing works

Th1/Th2 balance in cancer, transplantation and pregnancy

Shurin, M. R., Lü, L., Kaliński, P., Stewart‐Akers, A. M., & Lotze, M. T. (1999) · Springer Seminars in Immunopathology · doi:10.1007/bf00812261 · Cited by 214 · see citing works

Expression of RORγt Marks a Pathogenic Regulatory T Cell Subset in Human Colon Cancer

Blatner, N. R., Mulcahy, M. F., Dennis, K. L., Scholtens, D. M., Bentrem, D. J., Phillips, J. D., Ham, S., Sandall, B. P., Khan, M. W., Mahvi, D. M., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004566 · Cited by 214 · see citing works

Regulatory (FoxP3+) T-cell Tumor Infiltration Is a Favorable Prognostic Factor in Advanced Colon Cancer Patients Undergoing Chemo or Chemoimmunotherapy

Correale, P., Rotundo, M. S., Vecchio, M. T. D., Remondo, C., Migali, C., Ginanneschi, C., Tsang, K. Y., Licchetta, A., Mannucci, S., Loiacono, L., et al. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181d32f01 · Cited by 211 · see citing works

Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation

Piconese, S., Gri, G., Tripodo, C., Musio, S., Gorzanelli, A., Frossi, B., Pedotti, R., Pucillo, C. E. M., & Colombo, M. P. (2009) · Blood · doi:10.1182/blood-2009-05-220004 · Cited by 211 · see citing works

CD4+CD25+ Regulatory Lymphocytes Induce Regression of Intestinal Tumors in <i>ApcMin/+</i> Mice

Erdman, S. E., Sohn, J. J., Rao, V. P., Nambiar, P. R., Ge, Z., Fox, J. G., & Schauer, D. B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3104 · Cited by 211 · see citing works

Interleukin-10 promotes the maintenance of antitumor CD8+ T-cell effector function in situ

Fujii, S., Shimizu, K., Shimizu, T., & Lotze, M. T. (2001) · Blood · doi:10.1182/blood.v98.7.2143 · Cited by 208 · see citing works

IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses

Meyaard, L., Hovenkamp, E., Otto, S. A., & Miedema, F. F. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.8.2776 · Cited by 207 · see citing works

Intestinal Effector T Cells in Health and Disease

Maynard, C. L., & Weaver, C. T. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.012 · Cited by 207 · see citing works

Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice

Berman, R. M., Suzuki, T., Tahara, H., Robbins, P. D., Narula, S. K., & Lotze, M. T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.1.231 · Cited by 205 · see citing works

Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice

Marten, K., Bremer, C., Khazaie, K., Sameni, M., Sloane, B. F., Tung, C., & Weissleder, R. (2002) · Gastroenterology · doi:10.1053/gast.2002.30990 · Cited by 204 · see citing works

Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production.

Seder, R. A., Marth, T., Sieve, M. C., Strober, W., Letterio, J. J., Roberts, A. B., & Kelsall, B. L. (1998) · PubMed · Cited by 202 · see citing works

Starting at the Beginning: New Perspectives on the Biology of Mucosal T Cells

Cheroutre, H. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104522 · Cited by 196 · see citing works

Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells

Caux, C., Massacrier, C., Vanbervliet, B., Barthélémy, C., Liu, Y.-J., & Banchereau, J. (1994) · International Immunology · doi:10.1093/intimm/6.8.1177 · Cited by 192 · see citing works

CD4+ T Cell Clones Producing both Interferon-γ and Interleukin-10 Predominate in Bronchoalveolar Lavages of Active Pulmonary Tuberculosis Patients

Gerosa, F., Nisii, C., Righetti, S., Micciolo, R., Marchesini, M., Cazzadori, A., & Trinchieri, G. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4752 · Cited by 190 · see citing works

T-Regulatory Cells Shift from a Protective Anti-Inflammatory to a Cancer-Promoting Proinflammatory Phenotype in Polyposis

Gounaris, E. G., Blatner, N. R., Dennis, K. L., Magnusson, F. C., Gurish, M. F., Strom, T. B., Beckhove, P., Gounari, F., & Khazaie, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0304 · Cited by 189 · see citing works

Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection.

Knuth, A. K., Wölfel, T., Klehmann, E., Boon, T., & Büschenfelde, K. H. M. Z. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2804 · Cited by 188 · see citing works

Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory

Giovarelli, M., Musiani, P., Modesti, A., Dellabona, P., Casorati, G., Allione, A., Consalvo, M., Cavallo, F., Pierro, F. D., & Giovanni, C. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.6.3112 · Cited by 180 · see citing works

A molecular basis for T cell suppression by IL‐10: CD28‐associated IL‐10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3‐kinase binding

Akdiş, C. A., Joss, A., Akdiş, M., Faith, A., & Blaser, K. (2000) · The FASEB Journal · doi:10.1096/fj.99-0874fje · Cited by 180 · see citing works

Regulatory Role of T Cells Producing both Interferon γ and Interleukin 10 in Persistent Infection

Trinchieri, G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.f53 · Cited by 164 · see citing works

Interleukin-10 Increases Th1 Cytokine Production and Cytotoxic Potential in Human Papillomavirus-Specific CD8+Cytotoxic T Lymphocytes

Santin, A. D., Hermonat, P. L., Ravaggi, A., Bellone, S., Pecorelli, S. L., Roman, J. J., Parham, G. P., & Cannon, M. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4729-4737.2000 · Cited by 161 · see citing works

On the cellular basis of immunological T cell memory

Bruno, L., Kirberg, J., & von Boehmer, H. (1995) · Immunity · doi:10.1016/1074-7613(95)90077-2 · Cited by 159 · see citing works

Human Transferrin Receptor Gene as a Marker Gene for MR Imaging

Moore, A. V., Josephson, L., Bhorade, R. M., Basilion, J. P., & Weissleder, R. (2001) · Radiology · doi:10.1148/radiol.2211001784 · Cited by 156 · see citing works

Gut Barrier Dysfunction in the ApcMin/+ Mouse Model of Colon Cancer Cachexia

Puppa, M. J., White, J. P., Sato, S., Cairns, M., Baynes, J., & Carson, J. (2011) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2011.08.010 · Cited by 156 · see citing works

Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia

Haas, M., Dimmler, A., Hohenberger, W., Grabenbauer, G. G., Niedobitek, G., & Distel, L. V. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-65 · Cited by 154 · see citing works

Antimetastatic and Antitumor Activities of Interleukin 10 in a Murine Model of Breast Cancer

Kundu, N., Beaty, T. L., Jackson, M. J., & Fulton, A. M. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.8.536 · Cited by 154 · see citing works

Factors Involved in the Differentiation of TGF-β-Producing Cells from Naive CD4+ T Cells: IL-4 and IFN-γ Have Opposing Effects, While TGF-β Positively Regulates Its Own Production

Seder, R. A., Marth, T., Sieve, M. C., Strober, W., Letterio, J. J., Roberts, A. B., & Kelsall, B. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.5719 · Cited by 153 · see citing works

Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid

Khazaie, K., Zadeh, M., Khan, M. W., Bere, P., Gounari, F., Dennis, K., Blatner, N. R., Owen, J. L., Klaenhammer, T. R., & Mohamadzadeh, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207230109 · Cited by 149 · see citing works

In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction

Blatner, N. R., Bonertz, A., Beckhove, P., Cheon, E. C., Krantz, S. B., Strouch, M. J., Weitz, J., Koch, M., Halverson, A. L., Bentrem, D. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913683107 · Cited by 144 · see citing works

IL-23 receptor (IL-23R) gene protects against pediatric Crohnʼs disease

Dubinsky, M. C., Wang, D., Picornell, Y., Wrobel, I. T., Katzir, L., Quiros, A., Dutridge, D., Wahbeh, G. T., Silber, G. H., Bahar, R., et al. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20126 · Cited by 136 · see citing works

Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy

Ladoire, S., Arnould, L., Mignot, G., Coudert, B. P., Rébé, C., Chalmin, F., Vincent, J., Bruchard, M., Chauffert, B., Martin, F., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0831-1 · Cited by 135 · see citing works

Modifications of CD8+ T Cell Function during In Vivo Memory or Tolerance Induction

Tanchot, C., Guillaume, S., Delon, J., Bourgeois, C., Franzke, A., Sarukhan, A., Trautmann, A., & Rocha, B. (1998) · Immunity · doi:10.1016/s1074-7613(00)80563-4 · Cited by 130 · see citing works

IL-4 and IL-10 Antagonize IL-12-Mediated Protection Against Acute Vaccinia Virus Infection with a Limited Role of IFN-γ and Nitric Oxide Synthetase 21

van den Broek, M. F., Bachmann, M., Köhler, G., Barner, M., Escher, R., Zinkernagel, R., & Kopf, M. (2000) · Journal of Immunology · doi:10.4049/jimmunol.164.1.371 · Cited by 129 · see citing works

Re‐examination of the immunosuppressive mechanisms mediating non‐cure of Leishmania infection in mice

Sacks, D. L., & Anderson, C. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00185.x · Cited by 126 · see citing works

FoxP3+ Regulatory T Cells Suppress Effector T-Cell Function at Pathologic Site in Miliary Tuberculosis

Sharma, P. K., Saha, P. K., Singh, A. R., Sharma, S. K., Ghosh, B., & Mitra, D. K. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-529oc · Cited by 124 · see citing works

The SLAM family of immune-cell receptors

Veillette, A., & Latour, S. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00041-4 · Cited by 121 · see citing works

The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer

Khazaie, K., & von Boehmer, H. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.11.006 · Cited by 121 · see citing works

Control of intestinal homeostasis by regulatory T cells and dendritic cells

Coombes, J. L., & Maloy, K. J. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.01.001 · Cited by 121 · see citing works

IL-12 induces human T cells secreting IL-10 with IFN-γ

Windhagen, A., Anderson, D. E., Carrizosa, A., Williams, R. E., & Hafler, D. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.1127 · Cited by 119 · see citing works

The Interleukin‐23 / Interleukin‐17 axis in intestinal inflammation

Maloy, K. J. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01950.x · Cited by 119 · see citing works

IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain—containing protein tyrosine phosphatase 1

Taylor, A., Akdiş, M., Joss, A., Akkoç, T., Wenig, R., Colonna, M., Daigle, I., Flory, E., Blaser, K., & Akdiş, C. A. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.004 · Cited by 119 · see citing works

Mechanisms of allergen‐specific immunotherapy

Akdiş, C. A., & Blaser, K. (2000) · Allergy · doi:10.1034/j.1398-9995.2000.00120.x · Cited by 119 · see citing works

B-Cell-Derived IL-10: Production and Function

Burdin, N., Rousset, F., & Banchereau, J. (1997) · Methods · doi:10.1006/meth.1996.0393 · Cited by 115 · see citing works

The Production of IL-10 by Human Regulatory T Cells Is Enhanced by IL-2 through a STAT5-Responsive Intronic Enhancer in the IL-10 Locus

Tsuji‐Takayama, K., Suzuki, M., Yamamoto, M., Harashima, A., Okochi, A., Otani, T., Inoue, T., Sugimoto, A., Toraya, T., Takeuchi, M., et al. (2008) · Journal of Immunology · doi:10.4049/jimmunol.181.6.3897 · Cited by 112 · see citing works

Constitutive IL-10 Production Accounts for the High NK Sensitivity, Low MHC Class I Expression, and Poor Transporter Associated with Antigen Processing (TAP)-1/2 Function in the Prototype NK Target YAC-1

Petersson, M., Charo, J., Salazar‐Onfray, F., Noffz, G., Mohaupt, M., Qin, Z., Klein, G., Blankenstein, T. J. F., & Kiessling, R. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2099 · Cited by 109 · see citing works

Distinct Transcriptional Programs Activated by Interleukin-10 with or without Lipopolysaccharide in Dendritic Cells: Induction of the B Cell-Activating Chemokine, CXC Chemokine Ligand 13

Perrier, P., Martínez, F. O., Locati, M., Bianchi, G., Nebuloni, M., Vago, G. G., Bazzoni, F., Sozzani, S., Allavena, P., & Mantovani, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7031 · Cited by 108 · see citing works

Live Imaging of Cysteine-Cathepsin Activity Reveals Dynamics of Focal Inflammation, Angiogenesis, and Polyp Growth

Gounaris, E. G., Tung, C., Restaino, C. R., Maehr, R., Köhler, R. H., Joyce, J. A., Plough, H. L., Barrett, T. A., Weissleder, R., & Khazaie, K. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002916 · Cited by 108 · see citing works

HLA-G and IL-10 expression in human cancer—different stories with the same message

Urosevic, M., & Dummer, R. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(03)00024-5 · Cited by 105 · see citing works

IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity.

Lee, M. S., Mueller, R., Wicker, L. S., Peterson, L. B., & Sarvetnick, N. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2663 · Cited by 105 · see citing works

Tyk2 Negatively Regulates Adaptive Th1 Immunity by Mediating IL-10 Signaling and Promoting IFN-γ-Dependent IL-10 Reactivation

Shaw, M. H., Freeman, G. J., Scott, M. F., Fox, B. A., Bzik, D. J., Belkaid, Y., & Yap, G. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7263 · Cited by 104 · see citing works

IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells

Jeannin, P., Delneste, Y., Seveso, M., Life, P. F., & Bonnefoy, J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3159 · Cited by 93 · see citing works

Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection.

Pohl‐Koppe, A., Balashov, K. E., Steere, A. C., Logigian, E. L., & Hafler, D. A. (1998) · PubMed · Cited by 91 · see citing works

Interleukin-10 in the regulation of T cell-induced colitis

Annacker, O., Asseman, C., Read, S., & Powrie, F. M. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00045-3 · Cited by 89 · see citing works

IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform

Darrah, P. A., Hegde, S. T., Patel, D. T., Lindsay, R. W. B., Chen, L., Roederer, M., & Seder, R. A. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092532 · Cited by 86 · see citing works

A Synthetic Peptide Homologous to Functional Domain of Human IL-10 Down-Regulates Expression of MHC Class I and Transporter Associated with Antigen Processing 1/2 in Human Melanoma Cells

Kurte, M., López, M. N., Aguirre, A., Escobar, A. F., Aguillón, J. C., Charo, J., Larsen, C. G., Kiessling, R. W., & Salazar‐Onfray, F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1731 · Cited by 85 · see citing works

How to improve the immunogenicity of chemotherapy and radiotherapy

Ma, Y., Conforti, R., Aymeric, L., Locher, C., Kepp, O., Kroemer, G., & Zitvogel, L. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9283-2 · Cited by 82 · see citing works

Identification of a T Cell Subset Capable of both IFN-γ and IL-10 Secretion in Patients with Chronic Borrelia burgdorferi Infection

Pohl‐Koppe, A., Balashov, K. E., Steere, A. C., Logigian, E. L., & Hafler, D. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1804 · Cited by 79 · see citing works

Regulatory T-cell stability and plasticity in mucosal and systemic immune systems

Murai, M., Krause, P., Cheroutre, H., & Kronenberg, M. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.27 · Cited by 72 · see citing works

Anti-CTLA-4 treatment induces IL-10-producing ICOS + regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis

Coquerelle, C., Oldenhove, G., Acolty, V., Denoeud, J., Vansanten, G., Verdebout, J., Mellor, A. L., Bluestone, J. A., & Moser, M. (2009) · Gut · doi:10.1136/gut.2008.162842 · Cited by 71 · see citing works

Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones

Degiovanni, G., Lahaye, T., Hérin, M., Hainaut, P., & Boon, T. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180503 · Cited by 64 · see citing works

Mechanism of IL-10-Induced T Cell Inactivation in Allergic Inflammation and Normal Response to Allergens

Akdiş, C. A., Joss, A., Akdiş, M., & Blaser, K. (2001) · International Archives of Allergy and Immunology · doi:10.1159/000053704 · Cited by 62 · see citing works

Interleukin-12: a cytokine with therapeutic potential in oncology and infectious diseases.

Gately, M. K., Gubler, U., Brunda, M. J., Nadeau, R. R., Anderson, T. D., Lipman, J. M., & Sarmiento, U. M. (1994) · PubMed · Cited by 60 · see citing works

CXC chemokine receptor 4 expression and stromal cell‐derived factor‐1α‐induced chemotaxis in CD4+ T lymphocytes are regulated by interleukin‐4 and interleukin‐10

Jinquan, T., Quan, S., Jacobi, H., MADSEN, H. O., Glue, C., Skov, P. S., Malling, H., & Poulsen, L. K. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00954.x · Cited by 53 · see citing works

Down regulation of T-cell-derived IL-10 production by low-dose cyclophosphamide treatment in tumor-bearing rats restores in vitro normal lymphoproliferative response

Matar, P., Rozados, V. R., Gervasoni, S. I., & Scharovsky, O. G. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(00)00028-x · Cited by 53 · see citing works

Pegylated <scp>IL</scp>‐10 induces cancer immunity: The surprising role of IL‐10 as a potent inducer of IFN‐γ‐mediated CD8⁺ T cell cytotoxicity

Mumm, J. B., & Oft, M. (2013) · BioEssays · doi:10.1002/bies.201300004 · Cited by 53 · see citing works

Priming in the Presence of IL-10 Results in Direct Enhancement of CD8+ T Cell Primary Responses and Inhibition of Secondary Responses

Kang, S. S., & Allen, P. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5382 · Cited by 49 · see citing works

Cutting Edge: The Transcription Factor Kruppel-Like Factor 4 Regulates the Differentiation of Th17 Cells Independently of RORγt

Lebson, L. A., Gocke, A. R., Rosenzweig, J. M., Alder, J. K., Civin, C. I., Calabresi, P. A., & Whartenby, K. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002750 · Cited by 49 · see citing works

IL-10 enhances IL-2-induced proliferation and cytotoxicity by human intestinal lymphocytes

Ebert, E. C. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01147.x · Cited by 41 · see citing works

Prognostic Value of CD25 Expression on Lymphocytes and Tumor Cells in Squamous-Cell Carcinoma of the Head and Neck

Loose, D., Signore, A., Bonanno, E., Vermeersch, H., Dierckx, R., Deron, P. B., & de Wiele, C. V. (2008) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2007.0373 · Cited by 35 · see citing works

Inhibition of interleukin-10 (IL-10) production from MOPC 315 tumor cells by IL-10 antisense oligodeoxynucleotides enhances cell-mediated immune responses

Kim, B.-G., Joo, H., Chung, I.-S., Chung, H. Y., Woo, H.-J., & Yun, Y. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620000123 · Cited by 34 · see citing works

Current developments with peptide-based human tumor vaccines

Khazaie, K., Bonertz, A., & Beckhove, P. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328331a78e · Cited by 32 · see citing works

IL-10 suppresses CD2-mediated T cell activation via SHP-1

Taylor, A., Verhagen, J., Akkoç, T., Wenig, R., Flory, E., Blaser, K., Akdiş, M., & Akdiş, C. A. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.07.031 · Cited by 29 · see citing works

Regulatory T Lymphocytes Are Associated with Less Aggressive Histologic Features in Microsatellite-Unstable Colorectal Cancers

Tougeron, D., Maby, P., Elie, N., Fauquembergue, É., Pessot, F. L., Cornic, M., Sabourin, J., Michel, P., Frébourg, T., & Latouche, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061001 · Cited by 25 · see citing works

T cell receptors in an IL-10-secreting amino acid copolymer-specific regulatory T cell line that mediates bystander immunosuppression

Zhang, H., Stern, J. N. H., & Strominger, J. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813197106 · Cited by 8 · see citing works

Untitled work

Tsuchihashi (2000) · doi:10.1002/1521-4141(200006)30:6

Untitled work

(1999) · doi:10.1002/(sici)1521-4141(199909)29:09

Therapeutic cancer vaccines

Melief, C. J. M., van Hall, T., Arens, R., OSSENDORP, F. A., & van der Burg, S. H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80009 · Cited by 1,182 · see citing works

Rational Design of Immunomodulatory Hydrogels for Chronic Wound Healing

Kharaziha, M., Baidya, A., & Annabi, N. (2021) · Advanced Materials · doi:10.1002/adma.202100176 · Cited by 732 · see citing works

The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment

Kim, S. K., & Cho, S. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.868695 · Cited by 473 · see citing works

Balancing the immune response in the brain: IL-10 and its regulation

Lobo‐Silva, D., Carriche, G. M., Castro, A. G., Roque, S., & Saraiva, M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0763-8 · Cited by 427 · see citing works

Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches

Tufail, M., Jiang, C., & Li, N. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02280-1 · Cited by 424 · see citing works

The Biology of T Regulatory Type 1 Cells and Their Therapeutic Application in Immune-Mediated Diseases

Roncarolo, M. G., Gregori, S., Bacchetta, R., Battaglia, M., & Gagliani, N. (2018) · Immunity · doi:10.1016/j.immuni.2018.12.001 · Cited by 358 · see citing works

FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets

Saleh, R., & Elkord, E. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.07.022 · Cited by 355 · see citing works

APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment

Tai, Y., Acharya, C., An, G., Moschetta, M., Zhong, M. Y., Feng, X., Cea, M., Cagnetta, A., Wen, K., van Eenennaam, H., et al. (2016) · Blood · doi:10.1182/blood-2016-01-691162 · Cited by 352 · see citing works

Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC)

Chae, Y. K., Chang, S., Ko, T., Anker, J. F., Agte, S., Iams, W. T., Choi, W. M., Lee, K., & Cruz, M. R. D. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-21061-1 · Cited by 252 · see citing works

T Regulatory Cells and Priming the Suppressive Tumor Microenvironment

Paluskievicz, C., Cao, X., Abdi, R., Zheng, P., Liu, Y., & Bromberg, J. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02453 · Cited by 250 · see citing works

Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade

Taube, J. M., Young, G. D., McMiller, T. L., Chen, S., Salas, J. T., Pritchard, T. S., Xu, H., Meeker, A. K., Fan, J., Cheadle, C., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0244 · Cited by 248 · see citing works

Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis

Marshall, E. A., Ng, K. W., Kung, S. H. Y., Conway, E. M., Martínez, V. D., Halvorsen, E. C., Rowbotham, D. A., Vucic, E. A., Plumb, A. W., Becker‐Santos, D. D., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0551-1 · Cited by 230 · see citing works

Exercise training, circulating cytokine levels and immune function in cancer survivors: A meta-analysis

Khosravi, N., Stoner, L. R., Farajivafa, V., & Hanson, E. D. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.08.187 · Cited by 231 · see citing works

The Anti-Inflammatory Effects of Vitamin D in Tumorigenesis

Liu, W., Zhang, L., Xu, H., Li, Y., Hu, C.-M., Yang, J., & Sun, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092736 · Cited by 204 · see citing works

FOXP3+ Treg as a therapeutic target for promoting anti-tumor immunity

Whiteside, T. L. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1451514 · Cited by 196 · see citing works

CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies

Knochelmann, H. M., Smith, A. S., Dwyer, C. J., Wyatt, M. M., Mehrotra, S., & Paulos, C. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01740 · Cited by 186 · see citing works

Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups

Lin, W., Wu, S., Chen, X., Ye, Y., Weng, Y., Pan, Y., Chen, Z., Chen, L., Qiu, X., & Qiu, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00796 · Cited by 182 · see citing works

Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites

Perng, P., & Lim, M. K. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00153 · Cited by 166 · see citing works

Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis

Zhao, S., Wu, D., Wu, P., Wang, Z., & Huang, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139598 · Cited by 164 · see citing works

Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research

Lee, S. J., Yang, A. D., Wu, T. ‐., & Hung, C. (2016) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2016.27.e51 · Cited by 151 · see citing works

The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer.

Geginat, J., Larghi, P., Paroni, M., Nizzoli, G., Penatti, A. E., Pagani, M., Gagliani, N., Meroni, P. L., Abrignani, S., & Flavell, R. A. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.02.003 · Cited by 138 · see citing works

Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes

Qi, Y., Liu, B., Sun, Q., Xiong, X., & Chen, Q. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.578877 · Cited by 132 · see citing works

Turning tumors from cold to inflamed to improve immunotherapy response

Gerard, C. L., Delyon, J., Wicky, A. M., Homicskó, K., Cuendet, M. A., & Michielin, O. A. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102227 · Cited by 113 · see citing works

Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer

Feng, L., Qi, Q., Wang, P., Chen, H., Chen, Z., Meng, Z., & Liu, L. (2018) · Journal of International Medical Research · doi:10.1177/0300060518800588 · Cited by 113 · see citing works

Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity

Li, W., Guo, L., Rathi, P., Marinova, E., Gao, X., Wu, M.-F., Liu, H., Dotti, G., Gottschalk, S. M., Metelitsa, L. S., et al. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.025 · Cited by 107 · see citing works

Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer

Luo, X., Peng, X., Hou, J., Wu, S., Shen, J., & Wang, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s137245 · Cited by 107 · see citing works

IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients

Ahmad, N., Ammar, A., Storr, S. J., Green, A. R., Rakha, E. A., Ellis, I. O., & Martin, S. G. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2106-8 · Cited by 107 · see citing works

Interleukin-10-regulated tumour tolerance in non-small cell lung cancer

Vahl, J. M., Friedrich, J., Mittler, S., Trump, S., Heim, L., Kachler, K., Balabko, L., Fuhrich, N., Geppert, C., Trufa, D. I., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.336 · Cited by 105 · see citing works

The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma

Berti, F. C. B., Pereira, A. P. L., Cebinelli, G. C. M., Trugilo, K. P., & de Oliveira, K. B. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.03.002 · Cited by 103 · see citing works

Cytokine Regulation of Metastasis and Tumorigenicity

Yao, M., Brummer, G., Acevedo, D. S., & Cheng, N. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.05.005 · Cited by 96 · see citing works

Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications

Wu, P., Han, J., Gong, Y., Liu, C., Yu, H., & Xie, N. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14101990 · Cited by 95 · see citing works

The Treg/Th17 Paradigm in Lung Cancer

Duan, M., Zhong, X., Liu, G., & Wei, J. (2014) · Journal of Immunology Research · doi:10.1155/2014/730380 · Cited by 88 · see citing works

AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway

Pokhrel, R. H., Acharya, S., Ahn, J.-H., Gu, Y., Pandit, M., Kim, J., Park, Y., Kang, B., Ko, H., & Chang, J. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01420-9 · Cited by 86 · see citing works

Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors

Cheever, A., Townsend, M. H., & O'Neill, K. L. (2022) · Cells · doi:10.3390/cells11223626 · Cited by 89 · see citing works

The unique potency of Cowpea mosaic virus (CPMV) in situ cancer vaccine

Shukla, S., Wang, C., Beiss, V., Cai, H., Washington, T., Murray, A. A., Gong, X., Zhao, Z., Hema, M., Zlotnick, A., et al. (2020) · Biomaterials Science · doi:10.1039/d0bm01219j · Cited by 82 · see citing works

Cytokines and clinical predictors in distinguishing pulmonary transfusion reactions

Roubinian, N. H., Looney, M. R., Kor, D. J., Lowell, C. A., Gajic, O., Hubmayr, R. D., Gropper, M. A., Koenigsberg, M., Wilson, G. A., Matthay, M. A., et al. (2015) · Transfusion · doi:10.1111/trf.13021 · Cited by 80 · see citing works

The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues

Devi, K. S. P., & Anandasabapathy, N. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0602-0 · Cited by 81 · see citing works

Untitled work

(2022) · doi:10.1016/j.hsr.2021.100010 · Cited by 69 · see citing works

Cytokines, Adhesion Molecules, and Matrix Metalloproteases as Predisposing, Diagnostic, and Prognostic Factors in Venous Thrombosis

Mosevoll, K. A., Johansen, S., Wendelbo, Ø., Nepstad, I., Bruserud, Ø., & Reikvam, H. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00147 · Cited by 68 · see citing works

Excellent response to chemotherapy post immunotherapy

Dwary, A., Master, S. R., Patel, A., Cole, C., Mansour, R., Mills, G., Koshy, N., Peddi, P., Burton, G. V., Hammoud, D., et al. (2017) · OncoTarget · doi:10.18632/oncotarget.20030 · Cited by 60 · see citing works

Functionalized Nanoparticles Targeting Tumor-Associated Macrophages as Cancer Therapy

He, Y., Júnior, R. F. D. A., Cruz, L. J., & Eich, C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101670 · Cited by 65 · see citing works

Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals

Gardini, A. C., Foschi, F. G., Conti, F., Petracci, E., Vukotic, R., Marisi, G., Buonfiglioli, F., Vitale, G., Ravaioli, F., Gitto, S., et al. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.09.016 · Cited by 65 · see citing works

Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu

Colombo, M., Mirandola, L., Chiriva‐Internati, M., Basile, A., Locati, M., Lesma, E. A., Chiaramonte, R., & Platonova, N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01823 · Cited by 64 · see citing works

Cancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer control

Blaylock, R. L. (2015) · Surgical Neurology International · doi:10.4103/2152-7806.157890 · Cited by 65 · see citing works

Impact of proteolytic enzymes in colorectal cancer development and progression

Herszényi, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i37.13246 · Cited by 60 · see citing works

Scientific reports concerning the impact of interleukin 4, interleukin 10 and transforming growth factor on cancer cells

Kwaśniak, K., Czarnik-Kwaśniak, J., Maziarz, A., Aebisher, D., Zielińska, K., Karczmarek-Borowska, B., & Tabarkiewicz, J. (2019) · Central European Journal of Immunology · doi:10.5114/ceji.2018.76273 · Cited by 60 · see citing works

Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy

Mortezaee, K., & Majidpoor, J. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00667-8 · Cited by 46 · see citing works

Turning the Tide Against Regulatory T Cells

Han, S., Toker, A., Liu, Z. Q., & Ohashi, P. S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00279 · Cited by 57 · see citing works

In-vitro and in-vivo anti-breast cancer activity of OEO (Oliveria decumbens vent essential oil) through promoting the apoptosis and immunomodulatory effects

Jamali, T., Kavoosi, G., & Ardestani, S. K. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112313 · Cited by 56 · see citing works

Dendritic Cells in Sepsis: Pathological Alterations and Therapeutic Implications

Wu, D., Li, T., & Ji, X. (2017) · Journal of Immunology Research · doi:10.1155/2017/3591248 · Cited by 56 · see citing works

Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy

Pal, S. K., Moreira, D., Won, H., White, S. V., Duttagupta, P., Lúcia, M., Jones, J. O., Hsu, J., & Kortylewski, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081831 · Cited by 55 · see citing works

Regulator Versus Effector Paradigm: Interleukin-10 as Indicator of the Switching Response

Mingomataj, E., & Bakiri, A. H. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8514-7 · Cited by 54 · see citing works

Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma

Yu, C., Li, Q., Zhang, Y., Wen, Z., Dong, H., & Mou, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.941750 · Cited by 53 · see citing works

Chronic Lymphocytic Leukemia–Derived IL-10 Suppresses Antitumor Immunity

Alhakeem, S. S., McKenna, M. K., Oben, K. Z., Noothi, S. K., Rivas, J. R., Hildebrandt, G. C., Fleischman, R. A., Rangnekar, V. M., Muthusamy, N., & Bondada, S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800241 · Cited by 53 · see citing works

Mesenchymal stem cell therapy assisted by nanotechnology: a possible combinational treatment for brain tumor and central nerve regeneration

Kwon, S. C., Yoo, K. H., Sym, S. J., & Khang, D. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s217923 · Cited by 53 · see citing works

Bladder cancer cells induce immunosuppression of T cells by supporting PD‐L1 expression in tumour macrophages partially through interleukin 10

Wang, X., Ni, S., Chen, Q.-Y., Ma, L., Jiao, Z.-X., Wang, C., & Jia, G. (2016) · Cell Biology International · doi:10.1002/cbin.10716 · Cited by 52 · see citing works

CAR-T Cells in the Treatment of Ovarian Cancer: A Promising Cell Therapy

Zhang, X., Wu, Y., Xu, T., & Cui, M. (2023) · Biomolecules · doi:10.3390/biom13030465 · Cited by 51 · see citing works

Immune-Checkpoint Blockade Opposes CD8+ T-cell Suppression in Human and Murine Cancer

Pfannenstiel, L. W., Diaz-Montero, C. M., Tian, Y. F., Scharpf, J., Ko, J. S., & Gastman, B. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0054 · Cited by 49 · see citing works

Profiling of immune features to predict immunotherapy efficacy

Ye, Y., Zhang, Y., Yang, N., Gao, Q., Ding, X., Kuang, X., Bao, R., Zhang, Z., Sun, C., Zhou, B., et al. (2021) · The Innovation · doi:10.1016/j.xinn.2021.100194 · Cited by 46 · see citing works

Interleukin-10

Chang, C., Lam, H. Y. P., Hsu, H., & Jiang, S. (2021) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_162_20 · Cited by 46 · see citing works

Screening and Validation of the Hypoxia-Related Signature of Evaluating Tumor Immune Microenvironment and Predicting Prognosis in Gastric Cancer

Pei, J., Zhang, C., Yusupu, M., Zhang, C., & Dai, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705511 · Cited by 45 · see citing works

T-cell Expression of IL10 Is Essential for Tumor Immune Surveillance in the Small Intestine

Dennis, K. L., Saadalla, A. M., Blatner, N. R., Wang, S., Venkateswaran, V., Gounari, F., Cheroutre, H., Weaver, C. T., Roers, A., Egilmez, N. K., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0169 · Cited by 45 · see citing works

Recent Advances in Understanding the Mechanisms of Elemene in Reversing Drug Resistance in Tumor Cells: A Review

Tan, T., Li, J., Luo, R., Wang, R., Yin, L., Liu, M., Zeng, Y., Zeng, Z., & Xie, T. (2021) · Molecules · doi:10.3390/molecules26195792 · Cited by 44 · see citing works

Melittin Induced G1 Cell Cycle Arrest and Apoptosis in Chago-K1 Human Bronchogenic Carcinoma Cells and Inhibited the Differentiation of THP-1 Cells into Tumour- Associated Macrophages

Tipgomut, C., Wongprommoon, A., Takeo, E., Ittiudomrak, T., Puthong, S., & Chanchao, C. (2018) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2018.19.12.3427 · Cited by 43 · see citing works

Regulating the regulatory T cells as cell therapies in autoimmunity and cancer

Hosseinalizadeh, H., Rabiee, F., Eghbalifard, N., Rajabi, H., Klionsky, D. J., & Rezaee, A. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1244298 · Cited by 44 · see citing works

Natural killer cells in cancer immunotherapy

Wang, D., Dou, L., Sui, L., Xue, Y., & Xu, S. (2024) · MedComm · doi:10.1002/mco2.626 · Cited by 40 · see citing works

Fasciola hepatica glycoconjugates immuneregulate dendritic cells through the Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin inducing T cell anergy

Rodríguez, E., Kalay, H., Noya, V., Brossard, N., Giacomini, C., van Kooyk, Y., García-Vallejo, J. J., & Freire, T. (2017) · Scientific Reports · doi:10.1038/srep46748 · Cited by 40 · see citing works

Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients

Giunta, E. F., Barra, G., Falco, V. D., Argenziano, G., Napolitano, S., Vitale, P., Zanaletti, N., Terminiello, M., Martinelli, E., Morgillo, F., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-72711-2 · Cited by 39 · see citing works

Muscle-Derived Cytokines Reduce Growth, Viability and Migratory Activity of Pancreatic Cancer Cells

Schwappacher, R., Dieterich, W., Reljic, D., Pilarsky, C. P., Mukhopadhyay, D., Chang, D. K.-F., Biankin, A. V., Siebler, J., Herrmann, H. J., Neurath, M. F., et al. (2021) · Cancers · doi:10.3390/cancers13153820 · Cited by 39 · see citing works

IL-10 in cancer: an essential thermostatic regulator between homeostatic immunity and inflammation – a comprehensive review

Rallis, K. S., Corrigan, A. E., Dadah, H., Stanislovas, J., Zamani, P., Makker, S., Szabados, B. E., & Sideris, M. C. (2022) · Future Oncology · doi:10.2217/fon-2022-0063 · Cited by 45 · see citing works

Cholera-toxin suppresses carcinogenesis in a mouse model of inflammation-driven sporadic colon cancer

Doulberis, M., Angelopoulou, K., Kaldrymidou, E., Tsingotjidou, A., Abas, Z., Erdman, S. E., & Poutahidis, T. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu325 · Cited by 38 · see citing works

Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy

Nikolouzakis, T. K., Chrysos, E., Docea, A. O., Fragkiadaki, P., Souglakos, J., Tsiaoussis, J., & Tsatsakis, A. (2024) · Cancers · doi:10.3390/cancers16111995 · Cited by 37 · see citing works

Melatonin decreases and cytokines increase in women with placental insufficiency

Berbets, A. M., Koval, G. D., Barbe, A. M., Albota, O. M., & Yuzko, O. M. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1608432 · Cited by 35 · see citing works

Interleukin 10 promotes growth and invasion of glioma cells by up-regulating KPNA 2 in vitro

Sun, W., Zhang, Z., Huang, X., Li, J., Fan, H., Yang, F., Zhang, R., Yang, Y., Feng, S., Dong, H., et al. (2019) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_284_19 · Cited by 36 · see citing works

PARP Inhibition Activates STAT3 in Both Tumor and Immune Cells Underlying Therapy Resistance and Immunosuppression In Ovarian Cancer

Martincuks, A., Song, J., Kohut, A. Y., Zhang, C., Li, Y., Zhao, Q., Mak, E., Rodrı́guez-Rodrı́guez, L., Yu, H., & Cristea, M. C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.724104 · Cited by 37 · see citing works

A Comparative Study on Immunomodulatory Activity of Polysaccharides from Two Official Species ofGanoderma (Lingzhi)

Meng, L., Xie, J., Lv, G., Hu, D., Zhao, J., Duan, J., & Li, S. (2014) · Nutrition and Cancer · doi:10.1080/01635581.2014.948215 · Cited by 35 · see citing works

Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells

Gupta, N., Gaikwad, S. R., Kaushik, I., Wright, S. E., Markiewski, M. M., & Srivastava, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105150 · Cited by 35 · see citing works

Activated naïve B cells promote development of malignant pleural effusion by differential regulation of T H 1 and T H 17 response

Wu, X., Shi, X., Zhai, K., Yi, F., Wang, Z., Wang, W., Pei, X., Xu, L., Wang, Z., & Shi, H. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00120.2018 · Cited by 33 · see citing works

Novel Genomic Insights into Body Size Evolution in Cetaceans and a Resolution of Peto’s Paradox

Sun, D., Chai, S., Huang, X., Wang, Y., Xiao, L., Xu, S., & Yang, G. Z. (2021) · The American Naturalist · doi:10.1086/717768 · Cited by 32 · see citing works

Melittin-incorporated nanomedicines for enhanced cancer immunotherapy

Duan, X., Zou, H., Yang, J.-Z., Liu, S., Xu, T., & Ding, J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.08.047 · Cited by 32 · see citing works

Immunotherapy for pancreatic cancer

Kotteas, E. A., Saif, M. W., & Syrigos, K. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2119-2 · Cited by 31 · see citing works

Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO‐Silenced Dendritic Cell Vaccine

Sioud, M., Nyakas, M., Sæbøe‐Larssen, S., Mobergslien, A., Aamdal, S., & Kvalheim, G. (2016) · Case Reports in Medicine · doi:10.1155/2016/9639585 · Cited by 31 · see citing works

Immune checkpoint inhibitors: the new frontier in non–small cell lung cancer treatment

El-Osta, H. E., Shahid, K., Mills, G. M., & Peddi, P. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s111209 · Cited by 31 · see citing works

TYK2 in Tumor Immunosurveillance

Karjalainen, A., Shoebridge, S., Krunic, M., Simonović, N., Tebb, G., Macho‐Maschler, S., Strobl, B., & Müller, M. M. (2020) · Cancers · doi:10.3390/cancers12010150 · Cited by 31 · see citing works

Hot or cold: Bioengineering immune contextures into in vitro patient-derived tumor models

Too, N. S. H., Ho, N. C. W., Adine, C., Iyer, N. G., & Fong, E. L. S. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.001 · Cited by 31 · see citing works

Improvement of anti-tumor immunity of fibroblast activation protein α based vaccines by combination with cyclophosphamide in a murine model of breast cancer

Qiu, X., Zhang, F.-F., Geng, F., Liu, C., Wang, Y., Xu, P., Lu, Z.-Z., Xie, Y., Wu, H., Chen, Y., et al. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.08.006 · Cited by 31 · see citing works

The role of plant-derived natural substances as immunomodulatory agents in carcinogenesis

Samec, M., Líšková, A., Koklesová, L., Samuel, S. M., Murín, R., Žúbor, P., Bujnak, J., Kwon, T. K., Büsselberg, D., Prosecký, R., et al. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03424-2 · Cited by 30 · see citing works

Regulatory T Cells in the Tumor Microenvironment

Dadey, R., Workman, C. J., & Vignali, D. A. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49270-0_6 · Cited by 30 · see citing works

T-cell engaging poly(lactic-co-glycolic acid) nanoparticles as a modular platform to induce a potent cytotoxic immunogenic response against PD-L1 overexpressing cancer

Duwa, R., Pokhrel, R. H., Banstola, A., Pandit, M., Shrestha, P. S., Jeong, J., Chang, J., & Yook, S. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121911 · Cited by 30 · see citing works

Advances in natural killer cell therapies for breast cancer

Kiaei, S. Z. F., Nouralishahi, A., Ghasemirad, M., Barkhordar, M., Ghaffari, S., Kheradjoo, H., Saleh, M., Mohammadzadehsaliani, S., & Molaeipour, Z. (2023) · Immunology and Cell Biology · doi:10.1111/imcb.12658 · Cited by 30 · see citing works

Intraperitoneal Oxidative Stress in Rabbits with Papillomavirus-Associated Head and Neck Cancer Induces Tumoricidal Immune Response That Is Adoptively Transferable

Rossmann, A., Mandić, R., Heinis, J., Höffken, H., Küssner, O., Kinscherf, R., Weihe, E., & Bette, M. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0677 · Cited by 30 · see citing works

JAG2 signaling induces differentiation of CD14+ monocytes into Langerhans cell histiocytosis-like cells

Schwentner, R., Jug, G., Kauer, M. O., Schnöller, T., Waidhofer‐Söllner, P., Holter, W., & Hutter, C. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.1a0318-098r · Cited by 27 · see citing works

Immunohistochemical phenotyping of T cells, granulocytes, and phagocytes in the muscle of cancer patients: association with radiologically defined muscle mass and gene expression

Anoveros‐Barrera, A., Bhullar, A. S., Stretch, C., Dunichand‐Hoedl, A. R., Martins, K. J. B., Rieger, A. M., Bigam, D. L., McMullen, T. P. W., Bathe, O. F., Putman, C. T., et al. (2019) · Skeletal Muscle · doi:10.1186/s13395-019-0209-y · Cited by 28 · see citing works

Nano-trapping CXCL13 reduces regulatory B cells in tumor microenvironment and inhibits tumor growth

Shen, L., Li, J., Liu, Q., Das, M., Song, W., Zhang, X., Tiruthani, K., Dorosheva, O., Hu, H., Lai, S. K., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.039 · Cited by 28 · see citing works

Nanoparticle-based modulation of CD4+ T cell effector and helper functions enhances adoptive immunotherapy

Isser, A., Silver, A. B., Pruitt, H. C., Mass, M., Elias, E. H., Aihara, G., Kang, S.-S., Bachmann, N., Chen, Y., Leonard, E. K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33597-y · Cited by 28 · see citing works

Probiotic Lactobacillus rhamnosus modulates the gut microbiome composition attenuates preneoplastic colorectal Aberrant crypt foci

Gamallat, Y., Ren, X., Walana, W., Meyiah, A., Xinxiu, R., Zhu, Y., Li, M., Song, S., Xie, L., Jamalat, Y., et al. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.12.018 · Cited by 27 · see citing works

Innovative CAR-T Cell Therapy for Solid Tumor; Current Duel between CAR-T Spear and Tumor Shield

Jo, Y., Ali, L. A., Shim, J. A., Lee, B. H., & Hong, C. (2020) · Cancers · doi:10.3390/cancers12082087 · Cited by 27 · see citing works

PD-1/PD-L1 checkpoint inhibitors in combination with olaparib display antitumor activity in ovarian cancer patient-derived three-dimensional spheroid cultures

Appleton, K. M., Elrod, A. K., Lassahn, K. A., Shuford, S., Holmes, L. M., & DesRochers, T. M. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02849-z · Cited by 27 · see citing works

Antitumor, Immunomodulatory and Antiangiogenic Efficacy of Medicinal Mushroom Extract Mixtures in Advanced Colorectal Cancer Animal Model

Jakopović, B., Oršolić, N., & Pavelić, S. K. (2020) · Molecules · doi:10.3390/molecules25215005 · Cited by 27 · see citing works

Glioblastoma stem cell metabolism and immunity

Hawly, J., Murcar, M. G., Schcolnik‐Cabrera, A., & Issa, M. E. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10183-w · Cited by 29 · see citing works

IL-10 in cancer: Just a classical immunosuppressive factor or also an immunostimulating one?

Berti, F. C. B., & de Oliveira, K. B. (2018) · AIMS Allergy and Immunology · doi:10.3934/allergy.2018.2.88 · Cited by 24 · see citing works

Interleukin-10 and the immune response against cancer: a counterpoint

D, S. M. M., Marincola, F. M., & Young, H. A. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0705358 · Cited by 400 · see citing works

Effect of IL-10 in tumor

Zhou, J., & Tao, L. (2013) · Guoji zhongliuxue zazhi · doi:10.3760/cma.j.issn.1673-422x.2013.03.006

Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy

Sato, T., Terai, M., Tamura, Y., Alexeev, V. Y., Mastrangelo, M. J., & Selvan, S. R. (2011) · Immunologic Research · doi:10.1007/s12026-011-8262-6 · Cited by 287 · see citing works

Role of IL-10 in Cancer

Marincola, F. M. (2006) · CRC Press eBooks · doi:10.1201/9781498713405-21